Chronic Obstructive Pulmonary Disease Clinical Trial
— COPDMELODYOfficial title:
The Effect of Music Therapy in Pulmonary Rehabilitation of COPD Patients Aged 40-75
Chronic obstructive pulmonary disease(COPD) patients could benefit from pulmonary rehabilitation(PR) in better managing of the disease and its symptoms and in avoiding future relapses and hospitalizations. However, due to a large number of drop outs from PR, lack of professionals, and the COVID-19 epidemic, the PR has been underutilized, leading to a need for investigation of updated forms. Music therapy, such as rhythm-guided endurance training, singing training, listening to melody, may be one such potential relevant and motivating rehabilitation activity. The study aims to investigate the effects of home-based PR program with a rhythm-guided endurance walking exercise and singing training on both physiological and psychological aspects. Effects will be investigated in a randomized controlled trial (RCT) with 12-week intervention period.
Status | Recruiting |
Enrollment | 75 |
Est. completion date | December 2023 |
Est. primary completion date | December 2023 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 40 Years to 75 Years |
Eligibility | Inclusion Criteria: Participants with a clinical diagnosis of COPD and meeting the following criteria are eligible: 1. Diagnosis of GOLD II-IV and without acute exacerbation within the last 4 weeks. 2. Motivated for participating in the project (and acceptance of randomization) 3. Sufficient mobility to attend PR Exclusion Criteria: 1. Certain comorbidities (e.g. unstable coronary complications) 2. Severe cognitive disabilities (e.g. dementia) 3. Inability to cope with the program because of severe hearing or visual disorder. No previous singing experience or musical competence is required. |
Country | Name | City | State |
---|---|---|---|
China | China-Japan Friendship hospital | Beijing | Beijing |
Lead Sponsor | Collaborator |
---|---|
China-Japan Friendship Hospital |
China,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | incremental shuttle walking test(ISWT) distance | incremental shuttle walking test distance | 12 weeks | |
Secondary | Respiratory muscle strength | maximum inspiratory pressure(MIP), maximum expiratory pressure(MEP) | 12 weeks | |
Secondary | Spirometry | FEV1, FVC, FEV1/FVC, PEF, IC, RV, FRC, TLC | 12 weeks | |
Secondary | Short Physical Performance Battery(SPPB) | Test for health-related physical performance | 12 weeks | |
Secondary | modified British medical research council(mMRC) | It is a self-reported symptom questionnaire ranging from 0-4 score, higher scores mean a worse outcome. | 12 weeks | |
Secondary | COPD assessment test(CAT) | It is a self-reported quality of life questionnaire ranging from 0-10 score, higher scores mean a worse outcome. | 12 weeks | |
Secondary | St. George's Respiratory Questionnaire (SGRQ) | It is a self-reported symptom questionnaire ranging from 0-100 score, higher scores mean a worse outcome. | 12 weeks | |
Secondary | International Physical Activity Questionnaire Short Form (IPAQ-short) | It is a questionnaire evaluating participants' quantity of physical activity in a recent week. | 12 weeks | |
Secondary | Hospital Anxiety and Depression Scale(HADS) | It is a self-reported psychological status questionnaire ranging from 0-42 score, higher scores mean a worse outcome. | 12 weeks | |
Secondary | Compliance | Self-produced sheet with registration each time of each participant's attendance or absence (with or without cause). Registered continuously during intervention period. | 12 weeks |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT05102305 -
A Multi-center,Prospective, OS to Evaluate the Effectiveness of 'NAC' Nebulizer Therapy in COPD (NEWEST)
|
||
Completed |
NCT01867762 -
An Effectiveness and Safety Study of Inhaled JNJ 49095397 (RV568) in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease
|
Phase 2 | |
Recruiting |
NCT05562037 -
Stepped Care vs Center-based Cardiopulmonary Rehabilitation for Older Frail Adults Living in Rural MA
|
N/A | |
Terminated |
NCT04921332 -
Bright Light Therapy for Depression Symptoms in Adults With Cystic Fibrosis (CF) and COPD
|
N/A | |
Completed |
NCT03089515 -
Small Airway Chronic Obstructive Disease Syndrome Following Exposure to WTC Dust
|
N/A | |
Completed |
NCT02787863 -
Clinical and Immunological Efficiency of Bacterial Vaccines at Adult Patients With Bronchopulmonary Pathology
|
Phase 4 | |
Recruiting |
NCT05552833 -
Pulmonary Adaptive Responses to HIIT in COPD
|
N/A | |
Recruiting |
NCT05835492 -
A Pragmatic Real-world Multicentre Observational Research Study to Explore the Clinical and Health Economic Impact of myCOPD
|
||
Recruiting |
NCT05631132 -
May Noninvasive Mechanical Ventilation (NIV) and/or Continuous Positive Airway Pressure (CPAP) Increase the Bronchoalveolar Lavage (BAL) Salvage in Patients With Pulmonary Diseases?
|
N/A | |
Completed |
NCT03244137 -
Effects of Pulmonary Rehabilitation on Cognitive Function in Patients With Severe to Very Severe Chronic Obstructive Pulmonary Disease
|
||
Not yet recruiting |
NCT03282526 -
Volume Parameters vs Flow Parameters in Assessment of Reversibility in Chronic Obstructive Pulmonary Disease
|
N/A | |
Completed |
NCT02546700 -
A Study to Evaluate Safety and Efficacy of Lebrikizumab in Participants With Chronic Obstructive Pulmonary Disease (COPD)
|
Phase 2 | |
Withdrawn |
NCT04446637 -
Acute Bronchodilator Effects of Ipratropium/Levosalbutamol 20/50 mcg Fixed Dose Combination vs Salbutamol 100 mcg Inhaler Plus Ipratropium 20 mcg Inhalation Aerosol Free Combination in Patients With Stable COPD
|
Phase 3 | |
Completed |
NCT04535986 -
A Phase 3 Clinical Trial to Evaluate the Safety and Efficacy of Ensifentrine in Patients With COPD
|
Phase 3 | |
Recruiting |
NCT05865184 -
Evaluation of Home-based Sensor System to Detect Health Decompensation in Elderly Patients With History of CHF or COPD
|
||
Completed |
NCT03295474 -
Telemonitoring in Pulmonary Rehabilitation: Feasibility and Acceptability of a Remote Pulse Oxymetry System.
|
||
Completed |
NCT03256695 -
Evaluate the Relationship Between Use of Albuterol Multidose Dry Powder Inhaler With an eModule (eMDPI) and Exacerbations in Participants With Chronic Obstructive Pulmonary Disease (COPD)
|
Phase 3 | |
Withdrawn |
NCT04042168 -
Implications of Appropriate Use of Inhalers in Chronic Obstructive Pulmonary Disease (COPD)
|
Phase 4 | |
Completed |
NCT03414541 -
Safety And Efficacy Study Of Orally Administered DS102 In Patients With Chronic Obstructive Pulmonary Disease
|
Phase 2 | |
Completed |
NCT02552160 -
DETECT-Register DocumEnTation and Evaluation of a COPD Combination Therapy
|